EDGE
  • home.svg
    Home
  • news.svg
    All updates
  • news.svg
    EDGE Insights
  • list.svg
    Industries
  • db-search.svg
    Company Search
  • company-list.svg
    My Watchlists (Beta)
All Updates

All Updates

icon
Filter
Funding
RareCyte raises USD 20 million in venture funding to expand spatial biology platform
Precision Medicine
Jun 27, 2024
This week:
Partnerships
Qualcomm and Google partner to develop AI-driven automotive solutions
Auto Tech
Yesterday
Product updates
Meta AI releases LayerSkip to accelerate inference in LLMs
Generative AI Infrastructure
Yesterday
Funding
Freeform secures funding from NVIDIA's NVentures
Additive Manufacturing
Oct 22, 2024
Product updates
Flexxbotics announces compatibility with LMI Technologies for quality inspection
Smart Factory
Oct 22, 2024
Funding
Oxla raises USD 11 million in seed funding to drive commercialization
Data Infrastructure & Analytics
Oct 22, 2024
Product updates
Cohesity enhances Gaia, its AI assistant, with visual data exploration and expanded data sources
Data Infrastructure & Analytics
Oct 22, 2024
Product updates
Finzly launches FedNow service through BankOS platform in AWS marketplace
FinTech Infrastructure
Oct 22, 2024
Product updates
Runway launches Act-One for AI facial expression motion capture
Generative AI Applications
Oct 22, 2024
Product updates
Ideogram launches Canvas for image manipulation and generation
Generative AI Applications
Oct 22, 2024
Partnerships
UiPath partners with Inflection AI to integrate AI solutions for enterprises
Generative AI Applications
Oct 22, 2024
Precision Medicine

Precision Medicine

View industry hub
Jun 27, 2024

RareCyte raises USD 20 million in venture funding to expand spatial biology platform

Funding

  • RareCyte has raised USD 20 million in a venture funding round that included Forest Road, Arboretum Ventures, F-Prime Capital, HealthQuest Capital, 5AM Ventures, and Agilent Technologies.

  • The company plans to use the funds to expand RareCyte's primary platform, Orion Spatial Biology, which includes commercializing new multiplex assays, reagent products, and software applications. The funds will also enhance RareCyte's Precision Biology Services, such as spatial biology and liquid biopsy assays, and aid in global commercial expansion outside the US. 

  • Analyst Quicktake: The Orion spatial biology analysis platform was first made available for clinical research in 2020. In September 2021 , RareCyte raised USD 24 million in a Series G funding round to fast-track the platform's commercialization and applications. Arboretum Ventures led the round, which was jointly funded by new and existing investors.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.